We hypothesized that addition of IL-18, which can induce the proliferation of several immune effector cells through inducing IFNγ, major histocompatibility complex (MHC) class I expression, and also by inhibiting angiogenesis, could synergize with IL-27 to enhance tumor growth control. Here, IFNG is linked to neoplasm.